Showing 1,221 - 1,240 results of 2,004 for search '"Breast cancer"', query time: 0.11s Refine Results
  1. 1221
  2. 1222
  3. 1223
  4. 1224

    Matrine Inhibits Breast Cancer Cell Proliferation and Epithelial-Mesenchymal Transition Through Regulating the LINC01116/miR-9-5p/ITGB1 Axis by Lili Ren, Ziru Fang, Jiaojiao Xu, Xiaoxiao Wu, Yongjun Zhang, Hu Cai, Zhicun Han

    Published 2025-01-01
    “…Background: Breast cancer (BC) is the most prevalent solid cancer affecting women’s health globally. …”
    Get full text
    Article
  5. 1225

    Evaluation of the a-amylase enzyme, Carbohydrate Antigen CA-15.3 ( C.A 15.3),and some biochemical variables in the blood serum of breast cancer patients by Nagham abd, Ebtehal Sabri Mohammed, Amer Fadel Dawood

    Published 2025-01-01
    “… Evaluation of the amylase enzyme and some biochemical variables in the serum of breast cancer patients for all stages of the disease in patients compared to healthy women. …”
    Get full text
    Article
  6. 1226

    GrB-Fc-KS49, an anti-EMP2 granzyme B fusion protein therapeutic alters immune cell infiltration and suppresses breast cancer growth by Ana Alvarez de Cienfuegos, Lawrence H Cheung, Khalid A Mohamedali, Michael G Rosenblum, Brian Aguirre, Cheng-Hsiang Lu, Anubhav Chandla, Nidhi Kejriwal, Lucia Liu, Ann M Chan, SuYin Kok, Sergio Duarte, David Casero, Madhuri Wadehra

    Published 2024-12-01
    “…Epithelial membrane protein-2 (EMP2) is highly expressed in invasive breast cancer (BC), including triple-negative BC (TNBC), and represents an attractive therapeutic target.Methods We designed a novel fusion protein (GrB-Fc-KS49) composed of an active GrB fused to an anti-EMP2 single-chain antibody tethered through the immunoglobulin G heavy chain (Fc) domain. …”
    Get full text
    Article
  7. 1227
  8. 1228
  9. 1229

    Prognostic significance of total choline on in-vivo proton MR spectroscopy for prediction of late recurrence in patients with hormone receptor-positive, HER2-negative early breast cancer. by Hyunjik Kim, Heungkyu Park, Yongsoon Chun, Hagjun Kim, Hyeonman Baek, Yunyeong Kim

    Published 2025-01-01
    “…The present study assessed whether total choline (tCho), as measured by proton MRS, can predict late recurrence in patients with hormone receptor (HR)-positive, HER2-negative early breast cancer.<h4>Methods</h4>The study cohort included 261 HR+/HER2- breast cancer patients who underwent diagnostic single-voxel proton MRS (3.0T scanner) prior to first-line surgery from March 2011 to July 2014. …”
    Get full text
    Article
  10. 1230
  11. 1231
  12. 1232
  13. 1233
  14. 1234
  15. 1235
  16. 1236
  17. 1237
  18. 1238
  19. 1239
  20. 1240